2 results
Approved WMORecruiting
Compare the clinical efficacy of Epcoritamab to SOC (R-GemOx or BR)
Approved WMORecruiting
The aim of this prospective proof-of-concept study is to increase the expression of the SSTR2 in NET patients with negative or low expression to levels amenable for somatostatin analogue treatment through the use of epigenetic drugs.